Remove Antibody Remove Botox Remove Gene Remove RNA
article thumbnail

AbbVie Reports First-Quarter 2021 Financial Results

The Pharma Data

Global Botox Cosmetic net revenues were $477 million , an increase of 44.7 Global Botox Therapeutic net revenues were $532 million , an increase of 7.0 Botox Cosmetic*. Botox Therapeutic*. Global net revenues from the aesthetics portfolio were $1.141 billion , an increase of 34.9 percent on a comparable operational basis.

Botox 40
article thumbnail

Top 30 Pharma and Biotech Companies in 2023: Statistics and Trends

XTalks

2) Darzalex (daratumumab) Darzalex is a targeted monoclonal antibody that slows or stops the progression of multiple myeloma (a blood cancer) by binding to the CD38 protein on multiple myeloma cells. Meanwhile, BioMarin’s gene therapy Roctavian is approved by the FDA for the treatment of hemophilia A. billion in 2022, a 32.44

Sales 98